- Trials with a EudraCT protocol (33)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
33 result(s) found for: Cardiac physiology.
Displaying page 1 of 2.
| EudraCT Number: 2021-003310-39 | Sponsor Protocol Number: 2021_CHUSTP_DAPAMICRO | Start Date*: 2021-10-29 |
| Sponsor Name:CHU Saint Pierre | ||
| Full Title: Effect of the antidiabetic drug DAPAgliflozin on the coronary macrovascular and MICROvascular function in type 2 diabetic patients (DAPAMICRO) | ||
| Medical condition: Coronary macrovascular and microvascular function of type 2 diabetic patients with stable coronary artery disease and acute coronary syndrome (excluding ST elevation myocardial infarction). | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000788-26 | Sponsor Protocol Number: 3/085/11 | Start Date*: 2012-06-18 |
| Sponsor Name: [...] | ||
| Full Title: The Effects of Inorganic Nitrite on cardiac and skeletal muscle: Physiology, Pharmacology and Therapeutic Potential in patients with Chronic Heart Failure | ||
| Medical condition: Chronic heart failure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-002774-64 | Sponsor Protocol Number: HP 3.1 | Start Date*: 2007-12-04 |
| Sponsor Name:Deutsches Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler | ||
| Full Title: Therapy of PAH – Treatment with Sildenafil in Eisenmenger Patients | ||
| Medical condition: Patients with pre-existing congenital heart disease may develop Eisenmenger physiology (EP), characterized by development of pulmonary arterial hypertension and intracardiac right to left shunt. Th... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002926-35 | Sponsor Protocol Number: 080716CT | Start Date*: 2017-01-16 | |||||||||||
| Sponsor Name:Alder Hey Children's Foundation NHS Trust | |||||||||||||
| Full Title: Pharmacokinetics of post-operative Cefuroxime in infants undergoing cardiac surgery | |||||||||||||
| Medical condition: post operative paediatric cardiac patients | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-002316-12 | Sponsor Protocol Number: SR052012 | Start Date*: 2012-08-14 |
| Sponsor Name:University Hospitals of the KU Leuven | ||
| Full Title: The safety and feasibility of administering xenon to patients undergoing off-pump coronary artery bypass graft surgery: a pilot study XOPCAB – Xenon in Off-Pump Coronary Artery Bypass Grafting | ||
| Medical condition: Xenon anesthesia in cardiac surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000485-11 | Sponsor Protocol Number: SR022013 | Start Date*: 2013-04-24 |
| Sponsor Name:University Hospitals of the KU Leuven | ||
| Full Title: Xenon as an adjuvant to propofol anaesthesia in patients undergoing off-pump coronary artery bypass graft surgery: a randomized controlled trial | ||
| Medical condition: Xenon anesthesia in cardiac surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-002269-21 | Sponsor Protocol Number: 01.00240 | Start Date*: 2013-12-06 |
| Sponsor Name:Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto | ||
| Full Title: Metformin in diastolic dysfunction of metabolic syndrome | ||
| Medical condition: Diastolic dysfunction in non-diabetic patients with metabolic syndrome | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: PT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-020782-24 | Sponsor Protocol Number: 12578 | Start Date*: 2010-11-24 | |||||||||||
| Sponsor Name:Helsinki University Central Hospital | |||||||||||||
| Full Title: The effects of dexmedetomidine on cardiac electrophysiology in adults | |||||||||||||
| Medical condition: Myocardial electrophysiology of the patients with paroxysmal atrial fibrillation | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-003621-33 | Sponsor Protocol Number: ESR-15-10793 | Start Date*: 2016-02-25 | |||||||||||
| Sponsor Name:Fundación Interhospitalaria de Investigación Cardiovascular | |||||||||||||
| Full Title: PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor:A randomized multicenter clinical trial using intracoronary multimodal physiology | |||||||||||||
| Medical condition: Ischemic Heart Disease in Diabetic patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-000376-28 | Sponsor Protocol Number: 1245.148 | Start Date*: 2018-01-30 | |||||||||||
| Sponsor Name:Boehringer Ingelheim Limited | |||||||||||||
| Full Title: A randomised, double-blind, placebo-controlled, mechanistic cardiac magnetic resonance study to investigate the effects of empagliflozin treatment on cardiac physiology and metabolism in patients w... | |||||||||||||
| Medical condition: Chronic heart failure with reduced (HFrEF) and preserved ejection fraction (HFpEF) diagnosed at least 3 months prior to informed consent. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-001659-10 | Sponsor Protocol Number: S55481 | Start Date*: 2013-08-08 | |||||||||||
| Sponsor Name:UZLeuven | |||||||||||||
| Full Title: Acute effects of Sildenafil on the hemodynamics, Right Ventricle performance and cyclic GMP concentration in Heart failure patients with preserved left ventricular ejection fraction and patients af... | |||||||||||||
| Medical condition: To investigate acute effects of sildenafil on cardiac hemodynamics, right ventricle performance and cGMP concentrations in heart failure patients with preserved ejection fraction and patients after... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-003995-65 | Sponsor Protocol Number: TAKICARD-1 | Start Date*: 2015-11-25 | |||||||||||
| Sponsor Name:Västra Götalandsregionen, Sahlgrenska University Hospital /Queen Silvia children's hospital | |||||||||||||
| Full Title: Pharmacokinetics of ANP, a diuretic hormone, in neonates undergoing surgery for congenital heart defects. A pilot study. | |||||||||||||
| Medical condition: Acute renal failure after heart surgery | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-003968-39 | Sponsor Protocol Number: 2015CA02 | Start Date*: 2017-09-19 | ||||||||||||||||||||||||||
| Sponsor Name:University of Dundee/NHS Tayside | ||||||||||||||||||||||||||||
| Full Title: Renal and Cardiovascular Effects of SGLT2 inhibition in combination with loop diuretics in diabetic patients with chronic heart failure. | ||||||||||||||||||||||||||||
| Medical condition: Type 2 diabetes and heart failure | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2017-002709-36 | Sponsor Protocol Number: AK2017-3 | Start Date*: 2017-11-21 | ||||||||||||||||
| Sponsor Name:Rigshospitalet, Department of Physiology, Nuclear Medicine and PET | ||||||||||||||||||
| Full Title: Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ST-Elevation Myocardial Infarction(STEMI) | ||||||||||||||||||
| Medical condition: ST-Elevation Myocardial Infarction (STEMI) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2018-001494-24 | Sponsor Protocol Number: AK2015-10 | Start Date*: 2018-06-26 | |||||||||||
| Sponsor Name:Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET | |||||||||||||
| Full Title: In vivo molecular imaging of angiogenesis after VEGF-D gene therapy | |||||||||||||
| Medical condition: Ischemic heart disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-004596-31 | Sponsor Protocol Number: NL62772 | Start Date*: 2019-03-25 | ||||||||||||||||
| Sponsor Name:UMC Utrecht | ||||||||||||||||||
| Full Title: CeRebrUm and CardIac protection with Allopurinol in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass | ||||||||||||||||||
| Medical condition: Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2012-001390-88 | Sponsor Protocol Number: NT13034 | Start Date*: 2012-06-05 |
| Sponsor Name:Institute for Clinical and Experimental Medicine | ||
| Full Title: Cardioprotective and metabolic effects of metformin in patients with heart failure and diabetes | ||
| Medical condition: type 2 diabetes mellitus, heart failure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004828-11 | Sponsor Protocol Number: RECHMPL18_0038_prom_7574 | Start Date*: 2022-01-10 |
| Sponsor Name:University Hospital of Montpellier | ||
| Full Title: Phosphodiesterase-type 5 inhibitors in adult and adolescent patients with univentricular heart disease: a multi-center, randomized, double blind phase III study | ||
| Medical condition: adult and adolescent patients with univentricular heart diseases and pulmonary arterial pressure | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000201-72 | Sponsor Protocol Number: 1 | Start Date*: 2012-05-11 |
| Sponsor Name:University of Aberdeen [...] | ||
| Full Title: The Effects of Inorganic Nitrite on cardiac and skeletal muscle: Physiology, Pharmacology and Therapeutic Potential. Peripheral Arterial Disease | ||
| Medical condition: Peripheral arterial Disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000867-10 | Sponsor Protocol Number: CD13/10671 | Start Date*: 2014-02-13 | |||||||||||||||||||||
| Sponsor Name:University of Leeds | |||||||||||||||||||||||
| Full Title: Effects of Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction (HF-PEF): Cardiac MRI, Echocardiography, Exercise Physiology & Quality of Life Assessment | |||||||||||||||||||||||
| Medical condition: Heart failure with a preserved ejection fraction | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.